MovDisordV3, Main, Exploration, bibRecord, 002F85

Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases

Identifieur interne : 002F85 ( Main/Exploration ); précédent : 002F84; suivant : 002F86

Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases

Auteurs : Masato Kanazawa [Japon] ; Takayoshi Shimohata [Japon] ; Masahisa Sato [Japon] ; Osamu Onodera [Japon] ; Keiko Tanaka [Japon] ; Masatoyo Nishizawa [Japon]

Source :

Movement Disorders [ 0885-3185 ] ; 2007-03-15.

RBID : ISTEX:8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508

English descriptors

KwdEn :
- Adult, Apraxias (drug therapy), Apraxias (etiology), Apraxias (physiopathology), Blepharospasm (diagnosis), Botulinum Toxins, Type A (therapeutic use), Brain Stem (pathology), Brain Stem (physiopathology), Cerebellum (pathology), Cerebellum (physiopathology), Eyelids (physiopathology), Female, Humans, Infection, Magnetic Resonance Imaging, Male, Middle Aged, Neurodegenerative Diseases (complications), Neuromuscular Agents (therapeutic use), Parkinsonian Disorders (complications), Parkinsonian Disorders (pathology).
MESH :
- chemical , therapeutic use : Botulinum Toxins, Type A, Neuromuscular Agents.
- complications : Neurodegenerative Diseases, Parkinsonian Disorders.
- diagnosis : Blepharospasm.
- drug therapy : Apraxias.
- etiology : Apraxias.
- pathology : Brain Stem, Cerebellum, Parkinsonian Disorders.
- physiopathology : Apraxias, Brain Stem, Cerebellum, Eyelids.
- Adult, Female, Humans, Infection, Magnetic Resonance Imaging, Male, Middle Aged.

Url:

https://api.istex.fr/document/8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508/fulltext/pdf

DOI: 10.1002/mds.21367

Affiliations:

Japon

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases</title>
<author><name sortKey="Kanazawa, Masato" sort="Kanazawa, Masato" uniqKey="Kanazawa M" first="Masato" last="Kanazawa">Masato Kanazawa</name>
</author>
<author><name sortKey="Shimohata, Takayoshi" sort="Shimohata, Takayoshi" uniqKey="Shimohata T" first="Takayoshi" last="Shimohata">Takayoshi Shimohata</name>
</author>
<author><name sortKey="Sato, Masahisa" sort="Sato, Masahisa" uniqKey="Sato M" first="Masahisa" last="Sato">Masahisa Sato</name>
</author>
<author><name sortKey="Onodera, Osamu" sort="Onodera, Osamu" uniqKey="Onodera O" first="Osamu" last="Onodera">Osamu Onodera</name>
</author>
<author><name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name>
</author>
<author><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1002/mds.21367</idno>
<idno type="url">https://api.istex.fr/document/8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003E56</idno>
<idno type="wicri:Area/Istex/Curation">003E56</idno>
<idno type="wicri:Area/Istex/Checkpoint">001A93</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Kanazawa M:botulinum:toxin:a</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:17266083</idno>
<idno type="wicri:Area/PubMed/Corpus">002860</idno>
<idno type="wicri:Area/PubMed/Curation">002860</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002942</idno>
<idno type="wicri:Area/Ncbi/Merge">001A79</idno>
<idno type="wicri:Area/Ncbi/Curation">001A79</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001A79</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Kanazawa M:botulinum:toxin:a</idno>
<idno type="wicri:Area/Main/Merge">003F07</idno>
<idno type="wicri:Area/Main/Curation">002F85</idno>
<idno type="wicri:Area/Main/Exploration">002F85</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases</title>
<author><name sortKey="Kanazawa, Masato" sort="Kanazawa, Masato" uniqKey="Kanazawa M" first="Masato" last="Kanazawa">Masato Kanazawa</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Brain Research Institute, Niigata University, Niigata</wicri:regionArea>
<wicri:noRegion>Niigata</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shimohata, Takayoshi" sort="Shimohata, Takayoshi" uniqKey="Shimohata T" first="Takayoshi" last="Shimohata">Takayoshi Shimohata</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Brain Research Institute, Niigata University, Niigata</wicri:regionArea>
<wicri:noRegion>Niigata</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sato, Masahisa" sort="Sato, Masahisa" uniqKey="Sato M" first="Masahisa" last="Sato">Masahisa Sato</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Saiseikai Niigata Second Hospital, Niigata</wicri:regionArea>
<wicri:noRegion>Niigata</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Onodera, Osamu" sort="Onodera, Osamu" uniqKey="Onodera O" first="Osamu" last="Onodera">Osamu Onodera</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata</wicri:regionArea>
<wicri:noRegion>Niigata</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Brain Research Institute, Niigata University, Niigata</wicri:regionArea>
<wicri:noRegion>Niigata</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Brain Research Institute, Niigata University, Niigata</wicri:regionArea>
<wicri:noRegion>Niigata</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2007-03-15">2007-03-15</date>
<biblScope unit="vol">22</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="597">597</biblScope>
<biblScope unit="page" to="598">598</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508</idno>
<idno type="DOI">10.1002/mds.21367</idno>
<idno type="ArticleID">MDS21367</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Apraxias (drug therapy)</term>
<term>Apraxias (etiology)</term>
<term>Apraxias (physiopathology)</term>
<term>Blepharospasm (diagnosis)</term>
<term>Botulinum Toxins, Type A (therapeutic use)</term>
<term>Brain Stem (pathology)</term>
<term>Brain Stem (physiopathology)</term>
<term>Cerebellum (pathology)</term>
<term>Cerebellum (physiopathology)</term>
<term>Eyelids (physiopathology)</term>
<term>Female</term>
<term>Humans</term>
<term>Infection</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neurodegenerative Diseases (complications)</term>
<term>Neuromuscular Agents (therapeutic use)</term>
<term>Parkinsonian Disorders (complications)</term>
<term>Parkinsonian Disorders (pathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Botulinum Toxins, Type A</term>
<term>Neuromuscular Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Neurodegenerative Diseases</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Blepharospasm</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Apraxias</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Apraxias</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain Stem</term>
<term>Cerebellum</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Apraxias</term>
<term>Brain Stem</term>
<term>Cerebellum</term>
<term>Eyelids</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Infection</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Japon</li>
</country>
</list>
<tree><country name="Japon"><noRegion><name sortKey="Kanazawa, Masato" sort="Kanazawa, Masato" uniqKey="Kanazawa M" first="Masato" last="Kanazawa">Masato Kanazawa</name>
</noRegion>
<name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name>
<name sortKey="Onodera, Osamu" sort="Onodera, Osamu" uniqKey="Onodera O" first="Osamu" last="Onodera">Osamu Onodera</name>
<name sortKey="Sato, Masahisa" sort="Sato, Masahisa" uniqKey="Sato M" first="Masahisa" last="Sato">Masahisa Sato</name>
<name sortKey="Shimohata, Takayoshi" sort="Shimohata, Takayoshi" uniqKey="Shimohata T" first="Takayoshi" last="Shimohata">Takayoshi Shimohata</name>
<name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F85 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002F85 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508
   |texte=   Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases

Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.